Jupiter Neurosciences (JUNS) Current Leases (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Current Leases of $21247.0 for Q4 2025, down 57.58% year-over-year from $50082.0 in Q4 2024, and down 37.44% quarter-over-quarter from $33961.0 in Q3 2025.
Jupiter Neurosciences (JUNS) Current Leases (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Current Leases for 3 consecutive years, with $21247.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases fell 57.58% year-over-year to $21247.0; the TTM figure through Dec 2025 stood at $21247.0 (down 57.58% YoY), while the FY2025 annual figure was $21247.0, down 57.58% from the prior year.
- Current Leases slipped to $21247.0 in Q4 2025 per JUNS's latest filing, from $33961.0 in the prior quarter.
- Across five years, Current Leases topped out at $50556.0 in Q1 2025 and bottomed at $21247.0 in Q4 2025.
- Historically, Current Leases has averaged $42870.9 across 3 years, with a median of $48213.0 in 2023.
- Annual changes were most pronounced in 2024 — Current Leases advanced 3.88% — and 2025, when it tumbled 57.58%.
- Jupiter Neurosciences' Current Leases stood at $48213.0 in 2023, then rose by 3.88% to $50082.0 in 2024, then tumbled by 57.58% to $21247.0 in 2025.
- Business Quant data shows JUNS's Current Leases at $21247.0 in Q4 2025, $33961.0 in Q3 2025, and $46428.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | 15,539.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21,247.00 |
| Sep 30, 2025 | 33,961.00 |
| Jun 30, 2025 | 46,428.00 |
| Mar 31, 2025 | 50,556.00 |
| Dec 31, 2024 | 50,082.00 |
| Sep 30, 2024 | 49,609.00 |
| Dec 31, 2023 | 48,213.00 |